Skip to content

Startups

Artemesia BioMedical

Sectors
Health & Medicine

Launched
01/01/2008

Description

Artemesia BioMedical is the first biotechnology company to pioneer the development and commercialization of novel redesigned and repurposed artemisinin anti-malarial compounds for the treatment of cancer, inflammation and infectious diseases.

Team Members

Michael Kuran

Founder and CEO

Woerner Meehan

President